William Enright
Chief Executive Officer, Director · Barinthus Biotherapeutics plc.
Individual
- 2025
- Sep 9, 2026
- 4
Other insiders active in the same sector
No other insider has filed at William Enright's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $55.46M in COAG purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.95M in SMMT purchases and sales in the last 12 months
- Robert W. Duggan - $51.95M in SMMT purchases and sales in the last 12 months
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is William Enright?
William Enright is a corporate insider, tracked as Chief Executive Officer, Director of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has William Enright submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
